Home›Search›BioDrugs

BioDrugs

ADIS INT LTD · Switzerland · Est. 1997

ISSN1173-8804eISSN1179-190X

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

2.628

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.621

Total Worksi

1,691

Total Citationsi

48,976

2yr Mean Citednessi

6.42

Open Impact Factor alternative

Aims & Scope

An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease .

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published1997

FrequencySix No. A Year 2002-

StatusActive (last: 2026)

Total Publications1,691

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

APC Cost$5,490Above median

Peer Reviewdouble-blind

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

📦 Long-term Preservation

CLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

ADIS INT LTD

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1173-8804 / 1179-190X

✅

Indexed in a trusted database?

WoS, Scopus

✅

Peer review process documented?

double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$5,490

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

CLOCKSS

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

3.2k

2019

2.2k

2020

1.5k

2021

1.7k

2022

1.7k

2023

774

2024

320

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

BiotechnologyQ1

Medicine (miscellaneous)Q1

PharmacologyQ1

Pharmacology (medical)Q1

Subject Classification

Web of Science Categories

ImmunologyOncologyPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)BiotechnologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies ResearchRheumatoid Arthritis Research and TherapiesCAR-T cell therapy researchImmunotherapy and Immune ResponsesRNA Interference and Gene DeliveryInflammatory Bowel DiseasePharmaceutical Economics and PolicySystemic Lupus Erythematosus ResearchVirus-based gene therapy research

Frequently asked questions about BioDrugs

Is BioDrugs a predatory journal?

PubScope has no integrity flags on record for BioDrugs: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of BioDrugs?

BioDrugs is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.42.

Is BioDrugs indexed in Scopus and Web of Science?

BioDrugs is indexed in Web of Science, Scopus.

What is the aims and scope of BioDrugs?

How much does it cost to publish in BioDrugs?

BioDrugs charges an article processing charge (APC) of about $5,490 for open-access publication.